Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-15

FDA Approved: LANSOPRAZOLE — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approves Ajanta Pharma USA Inc.'s supplemental application to market generic lansoprazole.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lansoprazole (Lansoprazole)

Snippet

SUPPL AP for LANSOPRAZOLE (LANSOPRAZOLE)